[EN] AZAINDAZOLE AMIDE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS<br/>[FR] COMPOSÉS AZAINDAZOLE AMIDES EN TANT QU'ANTAGONISTES DES RÉCEPTEURS CCR1
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2011137109A1
公开(公告)日:2011-11-03
Disclosed are CCR1 inhibitor compounds of the formula (I): which are useful in the treatment of autoimmune and other diseases. Also disclosed a pharmaceutical compositions containing the same, and methods of making and using same.
AZAINDAZOLE AMIDE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS
申请人:Boehringer Ingelheim International GmbH
公开号:EP2563787B1
公开(公告)日:2014-11-26
OX1 ANTAGONISTS
申请人:Heptares Therapeutics Limited
公开号:EP3710435A1
公开(公告)日:2020-09-23
Azaindazole Amide Compounds As CCR1 Receptor Antagonists
申请人:Huber John D.
公开号:US20130203803A1
公开(公告)日:2013-08-08
Disclosed are CCR1 inhibitor compounds of the formula (I): which are useful in the treatment of autoimmune and other diseases. Also disclosed a pharmaceutical compositions containing the same, and methods of making and using same.